These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1521223)

  • 1. Enhanced expression of stomach cancer antigen derived from malignantly transformed bloom syndrome cells previously labeled with bromodeoxyuridine.
    Shiraishi Y; Ogata T; Soma H
    Cancer Genet Cytogenet; 1992 Aug; 62(1):1-8. PubMed ID: 1521223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromodeoxyuridine (BrdU) template and thymidine pool effects on high frequencies of sister-chromatid exchange (SCE) in Bloom syndrome cells and a mutant cell line (AsHa) originated from ataxia telangiectasia.
    Shiraishi Y; Li MJ
    Mutat Res; 1990 Jun; 230(2):177-86. PubMed ID: 2374555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cell fusion and deoxynucleosides on sister-chromatid exchanges in B-lymphoblastoid cell lines from 5 Bloom syndrome patients.
    Shiraishi Y
    Mutat Res; 1988 May; 199(1):75-83. PubMed ID: 2966298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of bromodeoxyuridine-associated sister chromatid exchanges in Bloom's syndrome cells with cycloheximide.
    Shiraishi Y; Yosida TH; Sandberg AA
    Cancer Genet Cytogenet; 1985 May; 17(1):43-54. PubMed ID: 3986750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristic mucinous ovarian cancer antigen is expressed in malignantly transformed Bloom's syndrome cells.
    Shiraishi Y; Yamamoto K; Soma H
    Cancer Res; 1993 Jul; 53(14):3427-32. PubMed ID: 8391927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparate effects of 5-bromodeoxyuridine on sister-chromatid exchanges and chromosomal aberrations in Bloom syndrome fibroblasts.
    Tsuji H; Heartlein MW; Latt SA
    Mutat Res; 1988 Mar; 198(1):241-53. PubMed ID: 2965297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Bromodeoxyuridine-dependent increase in sister chromatid exchange formation in Bloom's syndrome is associated with reduction in topoisomerase II activity.
    Heartlein MW; Tsuji H; Latt SA
    Exp Cell Res; 1987 Mar; 169(1):245-54. PubMed ID: 3028845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCE levels in Bloom-syndrome cells at very low bromodeoxyuridine (BrdU) concentrations: monoclonal anti-BrdU antibody.
    Shiraishi Y; Ohtsuki Y
    Mutat Res; 1987 Jan; 176(1):157-64. PubMed ID: 3540648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Western blotting analysis for malignant lymphoma and stomach cancer antigens from carcinogen-transformed Bloom syndrome cells.
    Shiraishi Y
    Int J Cancer; 1990 Apr; 45(4):783-7. PubMed ID: 2323853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromodeoxyuridine does not contribute to sister chromatid exchange events in normal or Bloom syndrome cells.
    van Wietmarschen N; Lansdorp PM
    Nucleic Acids Res; 2016 Aug; 44(14):6787-93. PubMed ID: 27185886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyses of bromodeoxyuridine-associated sister chromatid exchanges (SCEs) in Bloom syndrome based on cell fusion: single and twin SCEs in endoreduplication.
    Shiraishi Y; Yosida TH; Sandberg AA
    Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4369-73. PubMed ID: 6308619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased sister-chromatid exchanges (SCEs) and chromosomal fragilities by BrdU in a human mutant B-lymphoblastoid cell line.
    Taguchi T; Shiraishi Y
    Mutat Res; 1989 Mar; 211(1):43-9. PubMed ID: 2784189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant lymphoma antigen expressed in nude mouse tumor cells derived from carcinogen-transformed Bloom's syndrome B-lymphoblastoid cell lines.
    Shiraishi Y; Moriki T; Hara H; Araki K; Kozuru M; Sandberg AA
    Cancer Res; 1990 May; 50(10):3106-12. PubMed ID: 2185881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer antigens are expressed in a carcinogen-transformed Bloom syndrome B-lymphoblastoid cell line.
    Shiraishi Y; Soma H
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8211-5. PubMed ID: 3186719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromodeoxyuridine mutagenesis and deoxyribonucleotide pool imbalance in mammalian cells.
    Ashman CR; Kaufman ER; Davidson RL
    Basic Life Sci; 1985; 31():391-408. PubMed ID: 3888181
    [No Abstract]   [Full Text] [Related]  

  • 16. Uncorrected SCE levels of Bloom syndrome cells by cell hybridization with malignant cells with 14q32 structural abnormalities.
    Shiraishi Y; Li MJ
    Cancer Genet Cytogenet; 1993 Aug; 69(1):45-50. PubMed ID: 8374900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed DNA maturation, a possible cause of the elevated sister-chromatid exchange in Bloom's syndrome.
    Ockey CH; Saffhill R
    Carcinogenesis; 1986 Jan; 7(1):53-7. PubMed ID: 3943145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different properties in lymphoblastoid cell lines from patients with Bloom syndrome.
    Hashimoto T; Sukenaga T; Lopetegui P; Furuyama J
    Basic Life Sci; 1984; 29 Pt B():765-74. PubMed ID: 6099120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of sister chromatid exchange by 3-aminobenzamide is independent of bromodeoxyuridine.
    Morgan WF; Wolff S
    Cytogenet Cell Genet; 1984; 38(1):34-8. PubMed ID: 6705564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unique human mutant B-lymphoblastoid cell line (ataxia telangiectasia) which exhibits increased sister-chromatid exchange retaining hypersensitivity to neocarzinostatin and bleomycin.
    Li MJ; Shiraishi Y
    Mutat Res; 1990 Jun; 230(2):167-75. PubMed ID: 1695711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.